Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 326 participants.
Also called NCT07511257
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 326 participants
- Registry
-
NCT07511257
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Mexico
- Registry status
- Recruiting
Technical summary
Registry record NCT07511257. Randomized; no masking; primary purpose treatment. Start 2026-02-11 (actual); primary completion 2029-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia
- Acronym
- OVER-TIME II
- Condition
- Coronary Artery Ectasia
- Condition
- Acute Coronary Syndromes (ACS)
- Condition
- STEMI - ST Elevation Myocardial Infarction
- Condition
- NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
- Intervention (Drug)
- Aspirin 100 mg
- Intervention (Drug)
- Clopidogrel 75 mg
- Intervention (Drug)
- Rivaroxaban 15 mg
- Lead sponsor
- Instituto Nacional de Cardiologia Ignacio Chavez
Record details
- Record id
cardio:ct-nct07511257- Content hash
8476f63ca89d63dbf8b4d056828d81aa6c54620c10d4d6bca34e8e9abfc46291